Search results
Carlo Forlanini (11 June 1847 – 26 May 1918) was a medical doctor and professor at the Universities of Turin and Pavia. He was also the inventor of artificial pneumothorax, which was the primary treatment method of pulmonary tuberculosis for the first half of the 20th century and remained in use for severe cases of tuberculosis ...
Carlo Forlanini ( Milano, 11 giugno 1847 – Nervi, 26 maggio 1918) è stato un medico e inventore italiano . Indice. 1 Biografia. 2 Lo pneumotorace artificiale. 2.1 Tecnica del pneumotorace artificiale. 3 Principali lavori pubblicati. 4 Note. 5 Bibliografia. 6 Altri progetti. 7 Collegamenti esterni. Biografia.
11 de ago. de 2018 · A century ago: Carlo Forlanini and the first successful treatment of tuberculosis - The Lancet. Correspondence | Volume 392, ISSUE 10146, P475, August 11, 2018. Download Full Issue. A century ago: Carlo Forlanini and the first successful treatment of tuberculosis. Maria Carla Garbarino. Valentina Cani. Paolo Mazzarello.
Carlo Forlanini — 1847–1918. One hundred years have gone by since the birth of Carlo Forlanini, the originator of the systematic use of artificial pneumothorax as an independent therapeutic measure for the treatment of pulmonary tuberculosis. Born in Italy, he completed his medical studies at the age of 23.
This article reviews the life and work of Carlo Forlanini, a pioneer of collapse therapy for pulmonary tuberculosis in the late 19th century. He also made contributions to aerotherapy, clinical medicine, and medical education.
Carlo Forlanini (1847–1918) was a medical doctor who developed a method to treat tuberculosis by creating an artificial space between the lung and the chest wall. His invention, based on the theory of lung ventilation, was widely used until the discovery of antibiotics and influenced literature and culture.
El médico italiano Carlo Forlanini, nacido en 1847, siempre se interesó por la tuberculosis. Tras considerar cuidadosamente la teoría de lo que pensaba hacer, Forlanini procedió en 1888 a inducir el primer neumotórax artificial en un paciente con tuberculosis.
